Oral Lichen Planus: Etiology, Diagnosis, and Long-Term Management

Oral lichen planus is a chronic, immune-mediated inflammatory disease of the oral mucosa that affects up to two percent of the adult population. Because it carries a small but real risk of malignant transformation, accurate diagnosis and lifelong surveillance are essential.

Understanding the Condition

Oral lichen planus (OLP) results from a T-cell-mediated immune attack against basal keratinocytes of the oral epithelium. The trigger is unknown, although genetic susceptibility, stress, and certain systemic conditions have been implicated. It is more common in middle-aged women and typically runs a chronic, waxing and waning course.

The disease can affect any oral site, but the buccal mucosa, tongue, and gingiva are most frequently involved. Lesions are often bilateral and may be asymptomatic or cause significant discomfort depending on the clinical form.

Clinical Variants

Wickham striae are the hallmark white, lace-like lines that form at the periphery of lesions. Patients may have more than one variant simultaneously, and the reticular form frequently coexists with erosive or atrophic areas.

Diagnosis and Histopathology

Diagnosis rests on clinical appearance supported by biopsy. Histopathology classically shows a band-like lymphocytic infiltrate at the epithelial-connective tissue interface, basal cell degeneration, and saw-tooth rete ridges. Direct immunofluorescence may demonstrate fibrinogen deposition at the basement membrane zone.

A crucial part of the workup is excluding lichenoid reactions, which can mimic OLP clinically and histologically. Lichenoid drug reactions, contact reactions to dental materials such as amalgam, and oral lesions of lupus erythematosus must be considered, especially when lesions are unilateral or adjacent to restorations.

Medical Management

Asymptomatic reticular lesions require no treatment beyond observation. Symptomatic disease is managed stepwise, beginning with topical corticosteroids such as clobetasol, fluocinonide, or triamcinolone applied as gels, rinses, or adhesive pastes. Topical calcineurin inhibitors such as tacrolimus are a second-line option for refractory cases.

Systemic corticosteroids are reserved for severe or widespread disease, and other immunomodulators including hydroxychloroquine and systemic retinoids have been used with variable success. Because OLP is chronic, treatment aims at symptom control rather than cure, and patients should be counselled that flare-ups are expected.

Malignant Transformation Risk

The malignant transformation rate of oral lichen planus is generally reported between 0.5 and 2 percent, with erosive and atrophic forms carrying the highest risk. The tongue is the most common site of transformation. This low but significant risk mandates regular follow-up and biopsy of any suspicious change.

Risk factors for transformation include the erosive phenotype, long disease duration, tobacco and alcohol use, and possibly coinfection with Candida. Patients should be advised to avoid tobacco and alcohol and to maintain meticulous oral hygiene.

Long-Term Surveillance

Patients with OLP require periodic examination, typically every six to twelve months, with careful inspection of all oral mucosal surfaces and palpation of the tongue. Any area of induration, ulceration that fails to heal, or change in appearance warrants prompt biopsy.

Photographic documentation is valuable for tracking lesion evolution over time. A coordinated approach between the general dentist, oral medicine specialist, and pathologist ensures that changes are detected early and managed appropriately.

Living with Oral Lichen Planus

Beyond medication, patients benefit from avoiding spicy, acidic, and rough foods that aggravate erosions. Good plaque control reduces gingival inflammation, since plaque can worsen the gingival form of the disease. Stress management may also reduce the frequency of flare-ups.

Although OLP is a lifelong condition, most patients maintain a good quality of life with symptom control and reassurance. The key message is vigilance: with regular monitoring and early intervention, the small risk of malignant transformation can be effectively managed.

Differential Diagnosis

Several conditions mimic oral lichen planus and must be excluded before a definitive diagnosis. Lichenoid drug reactions, most commonly associated with antihypertensives, nonsteroidal anti-inflammatory drugs, and antimalarials, produce lesions that are often unilateral and resolve after the offending drug is withdrawn. Contact lichenoid reactions to amalgam or other dental materials appear adjacent to the restoration and improve after its replacement.

Oral lesions of lupus erythematosus, chronic graft-versus-host disease, and leukoplakia may also resemble OLP. Because management and prognosis differ, a careful medication history, examination of the skin, and histopathologic confirmation are essential steps in the workup.

Special Considerations

Desquamative gingivitis, a manifestation of OLP and other mucocutaneous disorders, presents as erythematous, painful gingiva that bleeds readily and does not respond to conventional plaque control alone. Recognition is important because these patients benefit from topical steroid therapy in addition to meticulous but gentle oral hygiene.

The erosive form of OLP can significantly impair eating and quality of life, and patients may become anxious about the cancer risk. Clear communication, realistic expectations, and a structured follow-up plan are central to managing both the physical and psychological burden of the disease.